YOD1 and head and neck squamous cell carcinoma: IHC staining showed that the expression of E-cadherin and TRIM33 was enhanced while the levels of N-cadherin and Ki67 decreased in the control group (Fig. 6E), indicating that YOD1 inhibited EMT and the proliferation of HNSCC cells.